Karthik Devarajan, Ph.D.
Affiliations: | 2000 | Northern Illinois University, DeKalb, IL, United States |
Area:
Statistics, Mathematics, Biostatistics BiologyGoogle:
"Karthik Devarajan"Parents
Sign in to add mentor| Nader Ebrahimi | grad student | 2000 | Northern Illinois University | |
| (Inference for a nonproportional hazards regression model and applications.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Asadi M, Devarajan K, Ebrahimi N, et al. (2022) Elaboration Models with Symmetric Information Divergence. International Statistical Review = Revue Internationale De Statistique. 90: 499-524 |
| Spirko-Burns L, Devarajan K. (2020) Supervised dimension reduction for large-scale "omics" data with censored survival outcomes under possible non-proportional hazards. Ieee/Acm Transactions On Computational Biology and Bioinformatics |
| Rengan AK, Dotan E, Devarajan K, et al. (2020) Genomic associations in metastatic pancreatic cancer (mPC). Journal of Clinical Oncology. 38: 765-765 |
| Winn JS, Hasse Z, Pei J, et al. (2020) Abstract P5-03-11: Germline and somatic variants in patients with inflammatory breast cancer (IBC) detected using cell-free DNA Cancer Research. 80 |
| Mancuso P, Tricarico R, Bhattacharjee V, et al. (2019) Thymine DNA glycosylase as a novel target for melanoma. Oncogene |
| O'Brien SB, Mutabdzic D, Handorf EA, et al. (2019) Stage II and III rectal adenocarcinoma outcomes related to lymphovascular invasion. Journal of Clinical Oncology. 37: 698-698 |
| Kozinova M, Joshi S, Devarajan K, et al. (2018) Abstract 4808: Combinations of imatinib mesylate with AKT inhibitor (miransertib, ARQ 751) or FGFR inhibitor (derazantinib) show synergy in GIST cell lines and preclinical models Cancer Research. 78: 4808-4808 |
| Ghatalia P, Devarajan K, Gordetsky J, et al. (2018) Abstract 3141: Immune gene expression and prognosis in localized clear cell (cc) renal cell carcinoma (RCC) Cancer Research. 78: 3141-3141 |
| Tricarico R, Mancuso P, Bhattacharjee V, et al. (2018) Abstract 1940: Thymine DNA glycosylase (TDG) as a novel target for melanoma Cancer Research. 78: 1940-1940 |
| Jiang W, Dulaimi E, Devarajan K, et al. (2017) Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma. Oncotarget |